U.S., Switzerland love to innovate together
A concentration of biotechnology and pharmaceutical companies explains the Swiss position atop the rankings, according to USISTF director Ann Liebschutz.
Send us a link
What awaits the new director
In the coming days, the US Senate will consider the confirmation of Dr. France Córdova as director of the NSF. If confirmed, Dr. Córdova will be the latest in a line of distinguished scientists to lead the nearly $7 billion agency.
Who's missing in modern academia: solitary geniuses or something much more significant?
Who's missing in modern academia: solitary geniuses or something much more significant?
When Peter Higgs, of Higgs boson fame, was quoted in the Guardian on Friday as saying "Today I wouldn't get an academic job" because he would not "be regarded as productive enough", it prompted much nodding and retweeting from academics.
Call the cops
The long arm of the law has reached into an investigation of alleged scientific misconduct in Italy.
Global gender disparities in science
Cassidy R. Sugimoto and colleagues present a bibliometric analysis confirming that gender imbalances persist in research output worldwide.
Manipulating Google Scholar metrics: simple, easy and tempting
Paper showing how to manipulate the Google Citations profiles of a research group through the creation of false documents that cite their documents, and consequently, the journals in which they have published modifying their H index.
The superior performance of migrant scientists
Scientists who move countries tend to publish in higher-impact journals than those who remain at home, a study finds
The Final Frontier
How do we support basic curiosity-driven research and maintain our position as the global leader in innovation and technology at a time of rapidly dwindling government funds?
NIH to experiment with high-risk grants
NIH considers supporting more individual researchers rather than projects.
Women scientists less likely to receive funding
Researchers uncovered evidence of women scientists working in the field of infectious diseases being disadvantaged in crucial funding allocations for more than a decade in the UK.
Nobel winner declares boycott of top science journals
Leading academic journals are distorting the scientific process and represent a "tyranny" that must be broken, according to Randy W. Schekman who has declared a boycott on the publications.
Posting your latest article? You might have to take it down
Researchers have been receiving notices from Academia.edu with takedown requests from Elsevier.
Fund to invest in life science companies in NYC
The Bloomberg administration and venture capitalists create a $100 million program for small firms.
GM maize, health and the Séralini affair
The journal Food and Chemical Toxicology has just retracted a controversial article published in September 2012 claiming a link between genetically modified maize and cancer.
DFG richtet neun weitere Sonderforschungsbereiche ein
Die Deutsche Forschungsgemeinschaft (DFG) richtet neun weitere Sonderforschungsbereiche (SFB) ein.
Peer reviewers urged to speak their minds
Controversial model points to benefits of more opinionated reviews.
How to fix peer review
Peer review, many boffins argue, channelling Churchill, is the worst way to ensure quality of research, except all the others. The system, which relies on papers being vetted by anonymous experts prior to publication, has underpinned scientific literature for decades.
Under strain around the globe
In the global marketplace of higher education, the humanities are increasingly threatened by decreased funding and political attacks.
UBS machte sich Uni Zürich gefügig
UBS machte sich Uni Zürich gefügig
Wie sich die UBS mit ihrer Spende von 100 Millionen Franken die Universität Zürich hörig machte.
Scientific journals should stop trying to be exciting - and focus on being right
Scientists desperate to have an "impact" in their field are cherry-picking and misrepresenting their results. It's the natural result of a desperate scramble to publish. Science, according to a recent Nature article, is like Battleship. You fire shots into the dark and mostly miss your target.
Top 20 things scientists need to know about policy-making
Top 20 things scientists need to know about policy-making
When scientists moan about how little politicians know about science, I usually get annoyed. Such grouching is almost always counterproductive and more often than not betrays how little scientists know about the UK's governance structures, processes, culture and history.
The case of the tuberculosis drugome
How easy is it to reproduce the results found in a typical computational biology paper? Either through experience or intuition the reader will already know that the answer is with difficulty or not at all.
Science magazine individual development career plan
An individual tool to help you explore career possibilities and set goals to follow the career path that fits you best.
LHC plans for open data future
When the Large Hadron Collider (LHC) is humming along, the data come in a deluge.
Scientific articles must be free for everyone to read in the Netherlands
Scientific articles written by Dutch researchers must be accessible for everyone to read free of charge from 2016.
Hampered by 'lack of long-term plan'
Peers criticise 'ad hoc' spending announcements on infrastructure
FDA tells google-backed 23andMe to halt DNA test service
The FDA is concerned about the public health consequences of inaccurate results from Google's personal genome service device.
Where does this leave the scientists?
Researchers can still operate by the rules and norms of science, but under Horizon 2020 they have - with the exception of the ERC - no autonomy to decide what science they do.
Research funding has become prone to bubble formation
Research funding has become prone to bubble formation
Research from the University of Copenhagen, which has just been published in the journal Philosophy and Technology, shows how the mechanisms that set off the financial crisis might be replicating in the field of science.
×